Cadila Pharmaceuticals reaffirms commitment to patient safety and regulatory compliance

Cadila Pharmaceuticals, a leading research-driven pharmaceutical company, has reaffirmed its commitment to patient safety following a recent regulatory communication concerning its Aciloc range.

To access the full article, please log in or subscribe.